Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

Presentation TCT 2025

Update on CREST-2, or Update on Best Medical Management of Symptomatic and Asymptomatic Cervical Carotid Stenosis

Presenter: Edip Gurol

October 28, 2025

Presentation TCT 2025

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

Presenter: Peter A. Soukas

October 28, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

Presentation TCT 2025

TCT 458: Invasive versus Conservative Management in Patients with Asymptomatic Ischemia: Insights from the ISCHEMIA Trial

Presenter: Sripal Bangalore

October 27, 2025

Presentation TCT 2025

TCT 838: Natural History and Outcomes of Early Aortic Valve Replacement versus Conservative Management in Patients with Asymptomatic Severe Aortic Stenosis: A Meta-Analysis

Presenter: Justin Huang

October 27, 2025

Presentation TCT 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Presenter: Joao L. Cavalcante

October 26, 2025

Presentation TCT 2025

Expanding Role of TAVI to Asymptomatic Severe Aortic Stenosis

Presenter: Philippe Genereux

October 26, 2025

Presentation TCT 2025

Predictors of a Positive Treadmill Stress Test in Patients with Asymptomatic Severe Aortic Stenosis: Insights from the EARLY TAVR Treadmill Registry

Presenter: Philippe Genereux

October 25, 2025

Presentation TCT 2024

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Presenter: Allan Schwartz

October 30, 2024

Presentation TCT 2024

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Presenter: Mark Dweck

October 30, 2024

Presentation TCT 2024

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

Presenter: Teresa Carman

October 29, 2024

Presentation TCT 2024

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient

Presenter: Steven Abramowitz

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Advertisement

Update on CREST-2, or Update on Best Medical Management of Symptomatic and Asymptomatic Cervical Carotid Stenosis

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

TCT 458: Invasive versus Conservative Management in Patients with Asymptomatic Ischemia: Insights from the ISCHEMIA Trial

TCT 838: Natural History and Outcomes of Early Aortic Valve Replacement versus Conservative Management in Patients with Asymptomatic Severe Aortic Stenosis: A Meta-Analysis

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Expanding Role of TAVI to Asymptomatic Severe Aortic Stenosis

Predictors of a Positive Treadmill Stress Test in Patients with Asymptomatic Severe Aortic Stenosis: Insights from the EARLY TAVR Treadmill Registry

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content